InspireMD (NSPR)

• Market cap: $74.3M
• 1 day: 1.06%
• 5 days: 1.06%
• 1 month: 18.75%
• 3 months: 4.01%
• 6 months: 5.56%
• Year to date: 5.17%
• 1 year: 7.55%
• 5 years: -78.16%
• 10 years: -100.00%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Employees: 80

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

17% more funds holding

Funds holding: 24 [Q2] → 28 (+4) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

5% less capital invested

Capital invested by funds: $35.1M [Q2] → $33.2M (-$1.92M) [Q3]

8.12% less ownership

Funds ownership: 56.36% [Q2] → 48.24% (-8.12%) [Q3]

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $4.50 58% upside
• Avg. target: $4.50 58% upside
• High target: $4.50 58% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Piper Sandler Adam Maeder 55% 1-year accuracy 6 / 11 met price target

58% upside $4.50

Overweight Reiterated

17 Sept 2024